Dermatologists provide clinical insights on how they discuss atopic dermatitis treatment options, considerations, and safety concerns with patients who are pregnant or of childbearing age.
Turn Therapeutics' Atopic Dermatitis Candidate Achieves 57% Reduction in Disease Severity in 7 Days
PODCAST: From Infection to Innovation - The Turn Therapeutics Story
Health Canada Authorizes Lebrikizumab for Moderate to Severe Atopic Dermatitis in Patients 12 Years and Older
The Cutaneous Connection: A Reminder of Patient Impact
Alexandra Golant, MD: Insights from Olympic Athlete Suni Lee's Journey with Atopic Dermatitis
Analyzing the Impact of AD on Women’s Sexual Health